CD14 and inflammatory bowel disease: The current MR analyses in our study suggested that genetically determined high neutrophil count may increase the risk of IBD and UC, and monocyte count (especially CD14- CD16+ monocyte absolute count) may reduce the risk of IBD and its main subtypes.